▶ 調査レポート

ドライアイ疾患診断及び治療の世界市場2020-2030:種類別(診断検査、治療)、疾患別

• 英文タイトル:Dry Eye Disease Diagnostics & Treatment Market (Type: Diagnostic Test and Treatment; and Disease: Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Transparency Market Researchが調査・発行した産業分析レポートです。ドライアイ疾患診断及び治療の世界市場2020-2030:種類別(診断検査、治療)、疾患別 / Dry Eye Disease Diagnostics & Treatment Market (Type: Diagnostic Test and Treatment; and Disease: Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 / D0SP21044資料のイメージです。• レポートコード:D0SP21044
• 出版社/出版日:Transparency Market Research / 2020年8月31日
• レポート形態:英文、PDF、220ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥654,835 (USD5,795)▷ お問い合わせ
  Multi User¥993,835 (USD8,795)▷ お問い合わせ
  Corporate License¥1,332,835 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ドライアイ疾患診断及び治療の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別(診断検査、治療)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)分析、競争状況などの構成でお届けいたします。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・ドライアイ疾患診断及び治療の世界市場:種類別(診断検査、治療)
・ドライアイ疾患診断及び治療の世界市場:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)
・競争状況

Dry Eye Disease Diagnostics & Treatment Market – Scope of the Report

TMR’s report on the global dry eye disease diagnostics & treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the overall market revenue of the global dry eye disease diagnostics & treatment market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global dry eye disease diagnostics & treatment market for the forecast period.

The report has been prepared after extensive primary and secondary research. Primary research involves bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global dry eye disease diagnostics & treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the global dry eye disease diagnostics & treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global dry eye disease diagnostics & treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global dry eye disease diagnostics & treatment market.

The report delves into the competition landscape of the global dry eye disease diagnostics & treatment market. Key players operating in the global dry eye disease diagnostics & treatment market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global dry eye disease diagnostics & treatment market that have been profiled in this report.

Key Questions Answered in Dry Eye Disease Diagnostics & Treatment Market Report

What is the sales/revenue generated by each type and disease segment of the global dry eye disease diagnostics & treatment market across all regions during the forecast period?
What are the opportunities in the global dry eye disease diagnostics & treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is likely to expand at the fastest CAGR during the forecast period?
Which dry eye disease diagnostics & treatment segments are expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market share or position of different companies operating in the global market in 2019?
Dry Eye Disease Diagnostics & Treatment Market – Research Objectives and Research Approach

The comprehensive report on the global dry eye disease diagnostics & treatment market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, pipeline analysis, key mergers & acquisitions, disease prevalence in key countries, technological advancements, and impact of COVID-19 in global dry eye disease diagnostics & treatment market have been provided.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global dry eye disease diagnostics & treatment market in terms of type, disease, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global dry eye disease diagnostics & treatment market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Dry Eye Disease Diagnostics & Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, 2018–2030

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis

5. Key Insights

5.1. Technological Advancements

5.2. Pipeline Analysis

5.3. Disease Prevalence & Incidence Rate globally with key countries

5.4. Key Mergers & Acquisitions

5.5. COVID-19 Pandemics Impact on Industry (short / mid / long term impact)

6. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, by Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Type, 2018–2030

6.3.1. Diagnostic Test

6.3.1.1. Schirmer’s Test

6.3.1.2. Corneal Staining

6.3.1.3. Tear Break-up Time (TBUT)

6.3.1.4. Optical Coherence Tomography (OCT)

6.3.1.5. Tear Film Stability Analysis

6.3.1.6. Tear Osmolarity

6.3.1.7. Others

6.3.2. Treatment

6.3.2.1. Artificial Tears

6.3.2.2. Anti-inflammatory

6.3.2.2.1. Cyclosporine

6.3.2.2.2. Corticosteroid

6.3.2.2.3. Others

6.3.2.3. Punctal Plugs

6.3.2.4. Secretagogue

6.3.2.5. Others

6.4. Market Attractiveness Analysis, by Type

7. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, by Disease

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Disease, 2018–2030

7.3.1. Evaporative Dry Eye Syndrome

7.3.2. Aqueous Dry Eye Syndrome

7.4. Market Attractiveness Analysis, by Disease

8. Global Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Market Attractiveness Analysis, by Country/Region

9. North America Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. Market Value Forecast, by Type, 2018–2030

9.2.1. Diagnostic Test

9.2.1.1. Schirmer’s Test

9.2.1.2. Corneal Staining

9.2.1.3. Tear Break-up Time (TBUT)

9.2.1.4. Optical Coherence Tomography (OCT)

9.2.1.5. Tear Film Stability Analysis

9.2.1.6. Tear Osmolarity

9.2.1.7. Others

9.2.2. Treatment

9.2.2.1. Artificial Tears

9.2.2.2. Anti-inflammatory

9.2.2.2.1. Cyclosporine

9.2.2.2.2. Corticosteroid

9.2.2.2.3. Others

9.2.2.3. Punctal Plugs

9.2.2.4. Secretagogue

9.2.2.5. Others

9.3. Market Value Forecast, by Disease, 2018–2030

9.3.1. Evaporative Dry Eye Syndrome

9.3.2. Aqueous Dry Eye Syndrome

9.4. Market Value Forecast, by Country, 2018–2030

9.4.1. U.S.

9.4.2. Canada

9.5. Market Attractiveness Analysis

9.5.1. By Type

9.5.2. By Disease

9.5.3. By Country

10. Europe Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Market Value Forecast, by Type, 2018–2030

10.2.1. Diagnostic Test

10.2.1.1. Schirmer’s Test

10.2.1.2. Corneal Staining

10.2.1.3. Tear Break-up Time (TBUT)

10.2.1.4. Optical Coherence Tomography (OCT)

10.2.1.5. Tear Film Stability Analysis

10.2.1.6. Tear Osmolarity

10.2.1.7. Others

10.2.2. Treatment

10.2.2.1. Artificial Tears

10.2.2.2. Anti-inflammatory

10.2.2.2.1. Cyclosporine

10.2.2.2.2. Corticosteroid

10.2.2.2.3. Others

10.2.2.3. Punctal Plugs

10.2.2.4. Secretagogue

10.2.2.5. Others

10.3. Market Value Forecast, by Disease, 2018–2030

10.3.1. Evaporative Dry Eye Syndrome

10.3.2. Aqueous Dry Eye Syndrome

10.4. Market Value Forecast, by Country/Sub-region, 2018–2030

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Market Attractiveness Analysis

10.5.1. By Type

10.5.2. By Disease

10.5.3. By Country/Sub-region

11. Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Type, 2018–2030

11.2.1. Diagnostic Test

11.2.1.1. Schirmer’s Test

11.2.1.2. Corneal Staining

11.2.1.3. Tear Break-up Time (TBUT)

11.2.1.4. Optical Coherence Tomography (OCT)

11.2.1.5. Tear Film Stability Analysis

11.2.1.6. Tear Osmolarity

11.2.1.7. Others

11.2.2. Treatment

11.2.2.1. Artificial Tears

11.2.2.2. Anti-inflammatory

11.2.2.2.1. Cyclosporine

11.2.2.2.2. Corticosteroid

11.2.2.2.3. Others

11.2.2.3. Punctal Plugs

11.2.2.4. Secretagogue

11.2.2.5. Others

11.3. Market Value Forecast, by Disease, 2018–2030

11.3.1. Evaporative Dry Eye Syndrome

11.3.2. Aqueous Dry Eye Syndrome

11.4. Market Value Forecast, by Country/Sub-region, 2018–2030

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Market Attractiveness Analysis

11.5.1. By Type

11.5.2. By Disease

11.5.3. By Country/Sub-region

12. Latin America Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Type, 2018–2030

12.2.1. Diagnostic Test

12.2.1.1. Schirmer’s Test

12.2.1.2. Corneal Staining

12.2.1.3. Tear Break-up Time (TBUT)

12.2.1.4. Optical Coherence Tomography (OCT)

12.2.1.5. Tear Film Stability Analysis

12.2.1.6. Tear Osmolarity

12.2.1.7. Others

12.2.2. Treatment

12.2.2.1. Artificial Tears

12.2.2.2. Anti-inflammatory

12.2.2.2.1. Cyclosporine

12.2.2.2.2. Corticosteroid

12.2.2.2.3. Others

12.2.2.3. Punctal Plugs

12.2.2.4. Secretagogue

12.2.2.5. Others

12.3. Market Value Forecast, by Disease, 2018–2030

12.3.1. Evaporative Dry Eye Syndrome

12.3.2. Aqueous Dry Eye Syndrome

12.4. Market Value Forecast, by Country/Sub-region, 2018–2030

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Market Attractiveness Analysis

12.5.1. By Type

12.5.2. By Disease

12.5.3. By Country/Sub-region

13. Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Type, 2018–2030

13.2.1. Diagnostic Test

13.2.1.1. Schirmer’s Test

13.2.1.2. Corneal Staining

13.2.1.3. Tear Break-up Time (TBUT)

13.2.1.4. Optical Coherence Tomography (OCT)

13.2.1.5. Tear Film Stability Analysis

13.2.1.6. Tear Osmolarity

13.2.1.7. Others

13.2.2. Treatment

13.2.2.1. Artificial Tears

13.2.2.2. Anti-inflammatory

13.2.2.2.1. Cyclosporine

13.2.2.2.2. Corticosteroid

13.2.2.2.3. Others

13.2.2.3. Punctal Plugs

13.2.2.4. Secretagogue

13.2.2.5. Others

13.3. Market Value Forecast, by Disease, 2018–2030

13.3.1. Evaporative Dry Eye Syndrome

13.3.2. Aqueous Dry Eye Syndrome

13.4. Market Value Forecast, by Country/Sub-region, 2018–2030

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Market Attractiveness Analysis

13.5.1. By Type

13.5.2. By Disease

13.5.3. By Country/Sub-region

14. Competition Landscape

14.1. Market Player – Competition Matrix (by tier and size of companies)

14.2. Market Share/Position Analysis, by Company, 2019

14.3. Competitive Business Strategies

14.4. Company Profiles

14.4.1. Novartis AG

14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.1.2. Company Financials

14.4.1.3. Growth Strategies

14.4.1.4. SWOT Analysis

14.4.2. Allergan plc

14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.2.2. Company Financials

14.4.2.3. Growth Strategies

14.4.2.4. SWOT Analysis

14.4.3. OASIS Medical

14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.3.2. Company Financials

14.4.3.3. Growth Strategies

14.4.3.4. SWOT Analysis

14.4.4. Santen Pharmaceutical Co., Ltd.

14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.4.2. Company Financials

14.4.4.3. Growth Strategies

14.4.4.4. SWOT Analysis

14.4.5. Johnson & Johnson

14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.5.2. Company Financials

14.4.5.3. Growth Strategies

14.4.5.4. SWOT Analysis

14.4.6. Otsuka Pharmaceutical Co., Ltd.

14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.6.2. Company Financials

14.4.6.3. Growth Strategies

14.4.6.4. SWOT Analysis

14.4.7. Advanced Tear Diagnostics

14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.7.2. Company Financials

14.4.7.3. Growth Strategies

14.4.7.4. SWOT Analysis

14.4.8. Tomey Corporation

14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.8.2. Company Financials

14.4.8.3. Growth Strategies

14.4.8.4. SWOT Analysis

14.4.9. Carl Zeiss Meditec AG

14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.9.2. Company Financials

14.4.9.3. Growth Strategies

14.4.9.4. SWOT Analysis

14.4.10. TearLab Corporation

14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.10.2. Company Financials

14.4.10.3. Growth Strategies

14.4.10.4. SWOT Analysis

14.4.11. Bausch Health Companies, Inc.

14.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.11.2. Company Financials

14.4.11.3. Growth Strategies

14.4.11.4. SWOT Analysis

14.4.12. RegeneRx (ReGenTree, LLC)

14.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)

14.4.12.2. Company Financials

14.4.12.3. Growth Strategies

14.4.12.4. SWOT Analysis

List of Tables

Table 01: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 02: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 03: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Treatment, 2018–2030

Table 04: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 05: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 06: Global Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 07: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 08: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 09: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 10: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Treatment, 2018–2030

Table 11: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 12: North America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 13: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 15: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 16: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Treatment, 2018–2030

Table 17: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 18: Europe Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 19: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 20: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Type, 2018–2030

Table 21: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 22: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Treatment, 2018–2030

Table 23: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 24: Asia Pacific Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Disease, 2018–2030

Table 25: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 27: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 28: Latin America Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Treatment, 2018–2030

Table 29: Latin America Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 30: Latin America Dry Eye Disease Diagnostics & Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030

Table 31: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 32: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Type, 2018–2030

Table 33: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Diagnostic Test, 2018–2030

Table 34: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Treatment, 2018–2030

Table 35: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 36: Middle East & Africa Dry Eye Disease Diagnostics & Treatment Market Size (US$ Mn) Forecast, by Disease, 2018–2030